Showing 34,621 - 34,640 results of 86,490 for search '(( 20 ((c decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.26s Refine Results
  1. 34621

    Supplementary Material for: Developmental Trajectories of Self-, Other-, and Dual-Harm across Adolescence: The Role of Relationships with Peers and Teachers by Steinhoff A. (11788868)

    Published 2022
    “…The participants self-reported self- and other-harm at 13, 15, 17, and 20 years. We assigned them to groups with self-, other-, dual- or no harm at specific assessments. …”
  2. 34622

    Prevaelnce of different pathogens by location. by Amete Mihret Teshale (12072758)

    Published 2025
    “…<div><p>Diarrheal illness remains a major global health challenge, causing millions of deaths annually. …”
  3. 34623

    Datasheet1_The causal relationship between human blood metabolites and risk of peripheral artery disease: a Mendelian randomization study.csv by Zhiyong Dong (1930624)

    Published 2024
    “…Importantly, in the reverse direction, PAD was found to be positively associated with increased levels of 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (p-18:0/20:4). This highlights the bidirectional nature of the association and suggests a potential feedback mechanism between PAD and this specific lipid species. 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (p-18:0/20:4) may serve as potential biomarkers for PAD, aiding early diagnosis and providing novel avenues for personalized treatment and management. …”
  4. 34624

    Datasheet2_The causal relationship between human blood metabolites and risk of peripheral artery disease: a Mendelian randomization study.csv by Zhiyong Dong (1930624)

    Published 2024
    “…Importantly, in the reverse direction, PAD was found to be positively associated with increased levels of 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (p-18:0/20:4). This highlights the bidirectional nature of the association and suggests a potential feedback mechanism between PAD and this specific lipid species. 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (p-18:0/20:4) may serve as potential biomarkers for PAD, aiding early diagnosis and providing novel avenues for personalized treatment and management. …”
  5. 34625
  6. 34626
  7. 34627

    Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry by Sylvia Haas (414005)

    Published 2025
    “…International guidelines recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke prevention in atrial fibrillation (AF). …”
  8. 34628

    Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry by Sylvia Haas (414005)

    Published 2016
    “…International guidelines recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke prevention in atrial fibrillation (AF). …”
  9. 34629
  10. 34630
  11. 34631
  12. 34632
  13. 34633

    Effect of a palliative care program on trends in intensive care unit utilization and do-not-resuscitate orders during terminal hospitalizations. An interrupted time series analysis by João Gabriel Rosa Ramos (5716646)

    Published 2018
    “…Interrupted time series analyses confirmed a trend of increased do-not-resuscitate order registrations, from an increase of 0.5% per month pre-implementation to an increase of 2.9% per month post-implementation (p < 0.001), and demonstrated a trend of decreased intensive care unit utilization, from an increase of 0.6% per month pre-implementation to a decrease of -0.9% per month in the post-implementation period (p = 0.001). …”
  14. 34634

    Effect of a palliative care program on trends in intensive care unit utilization and do-not-resuscitate orders during terminal hospitalizations. An interrupted time series analysis by João Gabriel Rosa Ramos (5716646)

    Published 2018
    “…Interrupted time series analyses confirmed a trend of increased do-not-resuscitate order registrations, from an increase of 0.5% per month pre-implementation to an increase of 2.9% per month post-implementation (p < 0.001), and demonstrated a trend of decreased intensive care unit utilization, from an increase of 0.6% per month pre-implementation to a decrease of -0.9% per month in the post-implementation period (p = 0.001). …”
  15. 34635

    Data Sheet 1_Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study.pdf by Ye Hong (2580841)

    Published 2025
    “…The greatest improvement was observed in the MGAE subgroup, with reductions of 69.8% ± 16.9% in MG-ADL, 51.8% ± 20.6% in QMG, 66.5% ± 20.2% in MGC. Clinically meaningful improvement (CMI) was rapidly achieved by 91.7% (11/12) of patients at 1.3 ± 0.5 weeks, with 8.3% (1/12) reaching minimal symptom expression (MSE) by week 4. …”
  16. 34636
  17. 34637
  18. 34638

    Table_1_Topical application of the plant extract SDTL-E in ovariectomized rats: A potential new approach for treating osteoporosis.DOCX by Hui-Yuan Shih (13985985)

    Published 2022
    “…SDTL-E Group was treated with SDTL-E, Model and Control Groups were treated with vegetable oil, treatments were topically applied twice daily for 20 days. Results showed when compared with Model Group, SDTL-E Group significantly restored serum estradiol back to near Control Group level, serum ALP activity, serum and urinary calcium were significantly decreased, bone mechanics indicators increased and trabecular bone numbers slightly increased. …”
  19. 34639

    Table1_Case report: Genetic analysis of a novel intronic inversion variant in the SPTB gene associated with hereditary spherocytosis.pdf by Bixin Xi (2408707)

    Published 2023
    “…The pathogenic variant can lead to exon 20 skipping and decreased SPTB gene expression. …”
  20. 34640